Democratizing hedge fund level analysis tools for everyone
| Name | Pyridam Farma Tbk |
| Sector | Healthcare |
| Industry | Pharmaceuticals & Health Care Research |
| Code | F2 |
| Latest Quarterly | 06-30-25 |
| Name | Latest % | A Month Ago % |
|---|---|---|
| Rejuve Global Investment PT. Ltd | 60.46 | 60.46 |
| Public < 5% | 34.45 | 34.45 |
| PT. Asuransi Jiwa Starinvestama | 5.1 | 5.1 |
| Source | 2022 | 2021 |
|---|---|---|
| PYFA | F2 | Pharmaceutical Products, Esthetic and Toll Products and Toll Manufacturing Services |
| PYFA | F2 | Medical Equipment |
| PYFA | F2 | Others |
| PYFA | F2 | Derma Products |
| Region | 2022 | 2021 |
|---|---|---|
| PYFA | F2 | Indonesia |
| PYFA | F2 | Others |
| Valuation | Ratio | Rank |
|---|---|---|
| P/S | 1.96 | # 12 / 15 |
| EV_EBITDA | -80.67 | --- / 15 |
| PER | -11.02 | --- / 15 |
| PBV | 8.41 | # 13 / 15 |
| DER | 8.44 | # 14 / 15 |
| Profitability | Ratio | Rank |
|---|---|---|
| NPM % | -17.756 | --- / 15 |
| ROA % | -7.049999999999999 | --- / 15 |
| ROE % | -76.03999999999999 | --- / 15 |
| Year | DPS | Yield [%] |
|---|---|---|
| 2019 | 1.72 | 0.8 |
| Timeframe | Performance |
|---|---|
| 1W % | -6.8 |
| 1Mo % | -7.7 |
| 3Mo % | 2.1 |
| 1Yr % | 71.4 |
| Stocks | PER | Market Cap | EV | Revenue | EBITDA | Net Profit |
|---|---|---|---|---|---|---|
| KLBF | 16.21 | 56.88 T | 58.14 T | 34,651 B | 5,348 B | 3,508 B |
| SOHO | 30.18 | 17.51 T | 19.64 T | 10,338 B | 711 B | 581 B |
| SIDO | 14.84 | 16.20 T | 15.77 T | 3,639 B | 1,481 B | 1,091 B |
| TSPC | 8.20 | 12.45 T | 10.93 T | 13,512 B | 2,016 B | 1,515 B |
| PYFA | -11.02 | 5.39 T | 11.42 T | 2,747 B | -142 B | -488 B |
| MDLA | 9.50 | 3.67 T | 6.27 T | 14,788 B | 557 B | 386 B |